Karyopharm Therapeutics reported $-43812000 in Operating Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbott ABT:US $ 2545M 1153M
Abbvie ABBV:US $ 4306M 135M
Acceleron Pharma XLRN:US $ -70.63M 6.97M
Amgen AMGN:US $ 2378M 1550M
Astrazeneca AZN:US -1674000000 2.8B
AstraZeneca AZN:LN -1674000000 2.8B
Avrobio Inc AVRO:US -32620000 1.24M
Biocryst Pharmaceuticals BCRX:US $ -44.58M 15M
Bristol Myers Squibb BMY:US $ 1996M 281M
Eli Lilly And LLY:US $ 1476M 72.6M
Enanta Pharmaceuticals ENTA:US $ -33.73M 0.12M
Epizyme EPZM:US $ -64140000 5.91M
GlaxoSmithKline GSK:LN 1.94B 263M
Johnson & Johnson JNJ:US $ 3849M 2813M
Karyopharm Therapeutics KPTI:US $ -43812000 5.24M
Macrogenics MGNX:US $ -52987000 12.71M
Merk MRK:US $ 4826M 3212M
Mirati Therapeutics MRTX:US $ -79.5M 84.69M
Nektar Therapeutics NKTR:US $ -113.6M 3.39M
Novartis NVS:US $ 3233M 246M
Novartis NOVN:VX 3.23B 246M
Pfizer PFE:US $ 7647M 1733M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Sangamo Biosciences SGMO:US $ -48.44M 0.26M
Takeda 4502:JP Y 97427M 151125M
Tg Therapeutics TGTX:US $ -85.13M 7.64M
Ultragenyx Pharmaceutical RARE:US $ -89.83M 7.05M
Xencor XNCR:US $ -41.9M 50.99M
YTE INCY:US $ 235.41M 94.57M